Nervosave Therapeutics
PrivateLast Round
Seed
Nov 27, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nervosave Therapeutics is a biotechnology company that develops a gene therapy platform for the treatment of peripheral nerve disorders, including Charcot-Marie-Tooth disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nervosave Therapeutics Comparables
Compare Nervosave Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Armatus Bio | 82% | |
| MAAsiRNA | 80% | |
| Novartis | 69% |
Nervosave Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 27, 2025 |
Nervosave Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SATT AxLR | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 70% MoM.
- Jul 24, 2026
Monthly visitors increased 275% MoM.
Nervosave Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nervosave Therapeutics's valuation, stock price, and market status.
Is Nervosave Therapeutics a public or private company?
Nervosave Therapeutics is a private company.
What is the current stock price of Nervosave Therapeutics?
Nervosave Therapeutics is a private company, so its shares have no public market price. Caplight tracks Nervosave Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nervosave Therapeutics worth (valuation)?
Valuation information for Nervosave Therapeutics is not publicly available.
Can I buy Nervosave Therapeutics stock?
Nervosave Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nervosave Therapeutics's last funding round?
Nervosave Therapeutics's most recent funding round was Seed on November 27, 2025.
Who are the main investors in Nervosave Therapeutics?
Key investors in Nervosave Therapeutics include SATT AxLR.
Will Nervosave Therapeutics IPO soon?
No public IPO plans have been announced for Nervosave Therapeutics.
How can I track Nervosave Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Nervosave Therapeutics's shares on secondary markets.